FDA Inspection 1181263 — Axolotl Biologix, Inc.
The FDA completed an inspection of Axolotl Biologix, Inc. on September 29, 2022 in Flagstaff, AZ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 29, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Flagstaff, AZ (United States)